Allergan, Inc. responds to Public Citizen’s allegation regarding a fatality following BOTOX(R) Cosmetic Treatment. – In response to public reports suggesting a causal link between a BOTOX(R) Cosmetic treatment in 2003 and a fatality, Allergan, Inc. (NYSE:AGN) provided further assurance to patients and the public about BOTOX(R) Cosmetic and BOTOX(R) (Botulinum Toxin Type A).
Botox and a similar injection Myobloc should come with stronger warnings following reports of 16 deaths after the botulinum toxin spread inside the body, a U.S. consumer group Public Citizen said.
– The Food and Drug Administration (FDA) should immediately increase its warnings and directly warn patients and doctors about the use of botulinum toxin ? available as Botox and Myobloc ? because of serious adverse reactions, including deaths, linked to the drug, Public Citizen said in a petition filed with the FDA.